 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Kamwokya Christian Caring Community (KCCC) |
| Street 1: | Plot 1495 off Old Kira Rd., Opposite Holy Trinity Church |
| Street 2: | |
| City: | Kampala |
| Province: | Central Region |
| Post Code: | 256 |
| Country: | Uganda |
| Phone: | +256414532600 |
| Email: | kamccc@kamccc.org |
| Web Site: | http://www.kamccc.org |
|
|
||||||||||||||||||||||||||||
General Information | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Faith-based organization (FBO) |
| Is your organization legally registered in your country: | Yes |
| Organization Reach: | National |
| Organization Description: | |
| Kamwokya Christian Caring Community (KCCC) is a faith based Non Government Organization established in 1987 by members of Small Basic Christian Communities (SBCCs) with the support of Sr. Dr. Miriam Duggan, to mitigate the negative medical economic, and social impact of HIV/AIDS and poverty in Kamwokya, Kampala district. KCCC being located in a densely populated slum area comprising of indigent people who live in shacks and with many cases of TB, is interested in eliminating TB among the indigent people in low resourced communities, providing free treatment and advocating for continued provision of TB drugs by government and TB prevention at the grassrootlevel. Currently KCCCC conducts massive TB prevention sensitisation talks in the communities including whorship centre, schools, village meetings, and daily health talks during clinic days. We also provide free TB treatment to patients, and we hold a monthly TB clinic day. We also conduct sputum investigations for TB, TB screening, counselling and directly observed therapy (DOT). We have a team of 33 Community Health Workers trained to follow up patients in the community so as to ensure adherence to medication. We work with family members so as to fight stigma and discrimination in the community and ensure social support to TB patients. |
|
| Total number of staff in your organization: | 51 - 99 |
| Number of full-time staff who are directly involved with TB: | 11 - 25 |
| Number of part-time staff who are directly involved with TB: | 0 |
| Number of volunteers who are directly involved with TB: | 26 - 50 |
| What is your organization's annual budget (USD) dedicated to TB? | $5,001-$10,000 |
| How did you hear about the Stop TB Partnership: | Stop TB communications |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Uganda |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| By providing free treatment for TB patients, working with resource limited communities to stop TB. Carrying out laboratory investigations for TB, conducting massive community sensitisation compaigns on TB prevention, counselling and referral for TB patients and advocacy. | |
Geographical Reach | |
| Which country is your headquarters located in: | Uganda |
| Which WHO region is the main focus of your work: | African |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Uganda |
Specializations | |
|
Advocacy, communication and social mobilization Research and Development TB Healthcare Services |
Specializations in Countries | |
| TB Healthcare Services | Uganda |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
DOTS Expansion and Enhancement: KCCC has a team of established Community Health Workers who follow up TB patients in their homes on a routine basis inorder to ensure adherence to medication and to document any other social and economic issues arising which impact on adherence on medication for patients. We initiate patients on therapy together with their care givers so as to ensure that family members understand the implications of TB and also support TB patients to adhere to medication and also to eliminate stigma and discrimination associated with TB/HIV/AIDS. We have mobilised and trained a critical mass of community leaders in our catchment area of Wakiso, Kampala and Mukono whom we call "Community Advocacy Focal Persons" (CAFOPs) These are charged with the responsibility of holding responsible duty bearers at all level of local government for providing them with health services in their communities TB,HIV/AIDS and malaria inclusive. Drug-Resistant TB: We do this by identifying patients who do not responde on TB drugs in the first 5 months due to different socio-economic problems and refer then to the National Hospital for furthere management. We follow up patients so as to ensure adherence to TB drugs, we provide continuous counselling for TB patients. TB-HIV: We screen all HIV and coughing patients who consult the clinic so as to identify TB patients and initiate them on drugs. we make sure that all TB patients are initiated on cotrimoxazole prophylaxis and later on ART because TB is the most dangerous opportunistic infection in HIV/AIDS care. Laboratory Strengthening: We carry our sputum investigations, quality control and quick issuing of sputum results so that patients are initiated on TB treatment on time. New microscopes such as the Florescent have been estalished to ensured proper diagnosis of TB New Diagnostics: This year we have launched a new TB treatment strategy called "Face TB" (One day diagnosis of TB), a patients provided two samples of sputum in the interval of one hour and the results are got after two to three hours. This has helped in the first tracking/screening of all coughing patients who would disappear after providing the spot sample. New TB Drugs: We are still administering a combination of Ethambutol, Rifampicin,Isoniazed and pyrazinamide as the initial phase of the first two months and Ethambutol and Isonaized for the remaining six months. Retreatment cases are given streptomycin injections with the initial phase for the two months and later on we continue with Refampicin, Isoniazed and Ethambutol. Operational Research: We conduct action research so as to inform treatment for TB and HIV/AIDS co-infected patients |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | August 10, 2012 |
| Last updated: | August 10, 2012 |